268 related articles for article (PubMed ID: 4891025)
1. [The behavior of hemodynamic values in hypertensive patients under treatment with dichlorophenylaminoimidazoline hydrochloride].
Pozenel H
Wien Klin Wochenschr; 1969 Mar; 81(10):187-92. PubMed ID: 4891025
[No Abstract] [Full Text] [Related]
2. [Behavior of hemodynamic values of patients with hypertension during dichlorphenylamino-imidazoline therapy].
Pozenel H
Wien Klin Wochenschr; 1969 Mar; 81(11):187-92. PubMed ID: 4935483
[No Abstract] [Full Text] [Related]
3. Hemodynamic effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) at rest and during exercise with special respect to the pulmonary circulation.
Koch G
Arzneimittelforschung; 1971 Jan; 21(1):57-61. PubMed ID: 5108382
[No Abstract] [Full Text] [Related]
4. Comparison between the effects of ST 600 and clonidine.
Kho TL; Schalekamp MA; Zaal GA; Wester A; Birkenhäger WH
Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):162-9. PubMed ID: 1190909
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and myocardial effects of (-)-delta9-trans-tetrahydrocannabinol in anesthetized dogs.
Cavero I; Buckley JP; Jandhyala BS
Eur J Pharmacol; 1973 Nov; 24(2):243-51. PubMed ID: 4765747
[No Abstract] [Full Text] [Related]
6. Comparison between the effects of ST 600 and catapres.
Kho TL; Schalekamp MA; Zaal GA; Wester A; Birkenhäger WH
Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):347-50. PubMed ID: 1156039
[TBL] [Abstract][Full Text] [Related]
7. Circulatory effects at rest and exercise of clonidine, an imidazoline derivative with hypotensive properties.
Muir AL; Burton JL; Lawrie DM
Lancet; 1969 Jul; 2(7613):181-4. PubMed ID: 4183136
[No Abstract] [Full Text] [Related]
8. [Hemodynamics and gas exchange following injection of 131-I-macroglbumin particles].
Konietzko N; Schlehe H; Rühle KH; Matthys H
Nucl Med (Stuttg); 1973 May; 12(1):56-63. PubMed ID: 4745558
[No Abstract] [Full Text] [Related]
9. [Clinical and experimental study with the new blood pressure depressant 2-(2,6-dichlorphenylamino)-2-imidazole-hydrochloride].
Grabner G; Michalek P; Pokorny D; Vormittag E
Arzneimittelforschung; 1966 Sep; 16(9):1174-9. PubMed ID: 6014738
[No Abstract] [Full Text] [Related]
10. The effects of 2-(2,6-dichlorphenylamine)-2-imidazoline hydrochloride (Catapres) upon the systemic and coronary haemodynamics and metabolism of intact dogs.
Maxwell GM
Arch Int Pharmacodyn Ther; 1969 Sep; 181(1):7-14. PubMed ID: 5350786
[No Abstract] [Full Text] [Related]
11. [Complex study of hypotensive agents -- a basis for rational pathogenatic treatment of hypertensive disease].
Kovalev GV; Tiurenkov IN
Kardiologiia; 1975 Aug; 15(8):125-7. PubMed ID: 1195540
[No Abstract] [Full Text] [Related]
12. The hemodynamics of hypertension and antihypertensive therapy.
Bender AD
Angiology; 1966 Sep; 17(9):627-39. PubMed ID: 5920103
[No Abstract] [Full Text] [Related]
13. Hemodynamic effects of Ro 23-6152 in patients with essential hypertension.
Folkers HB; van Zwienen JC; Boer P; Kleinbloesem CH; Geyskes GG
Eur J Clin Pharmacol; 1991; 41(4):307-11. PubMed ID: 1804644
[TBL] [Abstract][Full Text] [Related]
14. [Hemodynamic studies on the long-term therapy with 2-(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride].
Lori M
Dtsch Gesundheitsw; 1970 Jun; 25(23):1053-8. PubMed ID: 5524247
[No Abstract] [Full Text] [Related]
15. [Dopegit therapy of patients with hypertensive disease].
Savenkov PM; Zharov EI; Arshakuni RO; Kamanina NN; Ezhova IS
Kardiologiia; 1968 Oct; 8(10):131-6. PubMed ID: 5708799
[No Abstract] [Full Text] [Related]
16. Repeat hemodynamic studies in patients with arterial hypertension treated medically for several years.
Sannerstedt R; Schröder G; Werkö L
Acta Med Scand; 1971 Nov; 190(5):419-24. PubMed ID: 5149269
[No Abstract] [Full Text] [Related]
17. Pharmacodynamic effects of a new antihypertensive drug, Catapres (ST-155).
Onesti G; Schwartz AB; Kim KE; Swartz C; Brest AN
Circulation; 1969 Feb; 39(2):219-28. PubMed ID: 4884576
[No Abstract] [Full Text] [Related]
18. [Use of dimecarbin in the treatment of hypertension].
Kulago GV; Boreĭsho DE; Shpak VD
Kardiologiia; 1967 Mar; 7(3):128-31. PubMed ID: 5604597
[No Abstract] [Full Text] [Related]
19. [Hemodynamic effects of a new hypertensive agent (2',5'-dimethoxyphenyl-2 glycinamido-ethanol-1-hydrochlorid) following intravenous administration].
Hitzenberger G; Mösslacher H; Slany J
Int J Clin Pharmacol; 1973 Jul; 7(4):323-7. PubMed ID: 4580043
[No Abstract] [Full Text] [Related]
20. Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril).
Fouad FM; Tarazi RC; Bravo EL; Textor SC
Hypertension; 1984; 6(2 Pt 1):167-74. PubMed ID: 6327515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
